


{"id":43567,"date":"2020-10-21T11:58:08","date_gmt":"2020-10-21T09:58:08","guid":{"rendered":"https:\/\/newserver.fyb.de\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/"},"modified":"2020-10-21T11:58:08","modified_gmt":"2020-10-21T09:58:08","slug":"themis-beteiligungs-ag-sells-shares-in-dermapharm","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/","title":{"rendered":"Themis Beteiligungs AG sells shares in Dermapharm"},"content":{"rendered":"<p>Frank\u00adfurt \u2014 McDer\u00admott Will &amp; Emery advi\u00adses Joh. Beren\u00adberg, Goss\u00adler &amp; Co. KG (Beren\u00adberg) as Sole Global Coor\u00addi\u00adna\u00adtor and Sole Book\u00adrun\u00adner on the sale of shares in Derm\u00ada\u00adph\u00adarm Holding SE by Themis Betei\u00adli\u00adgungs-Akti\u00aden\u00adge\u00adsell\u00adschaft. The tran\u00adsac\u00adtion volume amounts to appro\u00adxi\u00adm\u00adately EUR 250 million.<\/p>\n<p>Derm\u00ada\u00adph\u00adarm is a leading manu\u00adfac\u00adtu\u00adrer of off-patent bran\u00added phar\u00admaceu\u00adti\u00adcals for selec\u00adted markets in Germany.<\/p>\n<p>The McDer\u00admott team led by part\u00adners Simon Wei\u00df and Joseph W. Marx regu\u00adlarly advi\u00adses Beren\u00adberg on capi\u00adtal market tran\u00adsac\u00adtions, most recently on the capi\u00adtal increase of CORESTATE Capi\u00adtal Holding S.A. and the capi\u00adtal measure of CompuGroup Medi\u00adcal SE &amp; Co.&nbsp;KGaA.<\/p>\n<p><strong>Advi\u00adsor Beren\u00adberg: McDer\u00admott Will &amp; Emery (Frank\u00adfurt)<\/strong><br>\nSimon Wei\u00df (Capi\u00adtal Markets) and Joseph W. Marx (US Capi\u00adtal Markets, both Lead), Andrea Adele Stock\u00adhorst (Finan\u00adcial Regu\u00adla\u00adtory); Asso\u00adciate: Isabelle M\u00fcller (Corpo\u00adrate)<\/p>\n<p>Inhouse Beren\u00adberg: Dr. Martin Knie\u00adhase (Head of Invest\u00adment Banking Legal Conti\u00adnen\u00adtal Europe, Direc\u00adtor) and Vanessa Harms, LL.M. (Asso\u00adciate Direc\u00adtor, Invest\u00adment Banking Legal)<\/p>\n<p><strong>About McDer\u00admott Will &amp;&nbsp;Emery<\/strong><br>\nMcDer\u00admott Will &amp; Emery Attor\u00adneys Tax LLP is a leading inter\u00adna\u00adtio\u00adnal law firm. With over 1,200 attor\u00adneys, we are repre\u00adsen\u00adted in 20 loca\u00adti\u00adons world\u00adwide: Atlanta, Boston, Brussels, Chicago, Dallas, D\u00fcssel\u00addorf, Frank\u00adfurt a.M., Hous\u00adton, London, Los Ange\u00adles, Miami, Milan, Munich, New York, Orange County, Paris, San Fran\u00adcisco, Sili\u00adcon Valley, Washing\u00adton, D.C. and Wilm\u00ading\u00adton. The German prac\u00adtice is mana\u00adged by McDer\u00admott Will &amp; Emery Rechts\u00adan\u00adw\u00e4lte Steu\u00ader\u00adbe\u00adra\u00adter LLP. www.mwe.com<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Frank\u00adfurt \u2014 McDer\u00admott Will &amp; Emery advi\u00adses Joh. Beren\u00adberg, Goss\u00adler &amp; Co. KG (Beren\u00adberg) as Sole Global Coor\u00addi\u00adna\u00adtor and Sole Book\u00adrun\u00adner on the sale of shares in Derm\u00ada\u00adph\u00adarm Holding SE by Themis Betei\u00ad\u00adli\u00ad\u00adgungs-Akti\u00aden\u00ad\u00adge\u00ad\u00adsel\u00adl\u00ad\u00adschaft. The tran\u00adsac\u00adtion volume amounts to appro\u00adxi\u00adm\u00adately EUR 250 million. Derm\u00ada\u00adph\u00adarm is a leading manu\u00adfac\u00adtu\u00adrer of off-patent bran\u00added phar\u00admaceu\u00adti\u00adcals for selec\u00adted markets in&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":35368,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1365,1366,1367,1368,1369],"tags":[],"class_list":["post-43567","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-private-equity-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors","category-investors","news-category-private-equity-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Themis Beteiligungs AG sells shares in Dermapharm - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Themis Beteiligungs AG sells shares in Dermapharm - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Frank\u00adfurt \u2014 McDer\u00admott Will &amp; Emery advi\u00adses Joh. Beren\u00adberg, Goss\u00adler &amp; Co. KG (Beren\u00adberg) as Sole Global Coor\u00addi\u00adna\u00adtor and Sole Book\u00adrun\u00adner on the sale of shares in Derm\u00ada\u00adph\u00adarm Holding SE by Themis Betei\u00adli\u00adgungs-Akti\u00aden\u00adge\u00adsell\u00adschaft. The tran\u00adsac\u00adtion volume amounts to appro\u00adxi\u00adm\u00adately EUR 250 million. Derm\u00ada\u00adph\u00adarm is a leading manu\u00adfac\u00adtu\u00adrer of off-patent bran\u00added phar\u00admaceu\u00adti\u00adcals for selec\u00adted markets in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-21T09:58:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/10\/a-weiss_simon.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Themis Beteiligungs AG sells shares in Dermapharm\",\"datePublished\":\"2020-10-21T09:58:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/\"},\"wordCount\":232,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/10\/a-weiss_simon.jpg\",\"articleSection\":[\"General\",\"Featured\",\"Private equity\",\"News\",\"Lawyers\/Tax-advisors\/Auditors\",\"Lawyers, tax consultants, auditors\",\"Investors\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/\",\"url\":\"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/\",\"name\":\"Themis Beteiligungs AG sells shares in Dermapharm - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/10\/a-weiss_simon.jpg\",\"datePublished\":\"2020-10-21T09:58:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/10\/a-weiss_simon.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/10\/a-weiss_simon.jpg\",\"width\":600,\"height\":600,\"caption\":\"Gittings Photography\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Themis Beteiligungs AG sells shares in Dermapharm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Themis Beteiligungs AG sells shares in Dermapharm - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/","og_locale":"en_US","og_type":"article","og_title":"Themis Beteiligungs AG sells shares in Dermapharm - FYB Financial Yearbook","og_description":"Frank\u00adfurt \u2014 McDer\u00admott Will &amp; Emery advi\u00adses Joh. Beren\u00adberg, Goss\u00adler &amp; Co. KG (Beren\u00adberg) as Sole Global Coor\u00addi\u00adna\u00adtor and Sole Book\u00adrun\u00adner on the sale of shares in Derm\u00ada\u00adph\u00adarm Holding SE by Themis Betei\u00adli\u00adgungs-Akti\u00aden\u00adge\u00adsell\u00adschaft. The tran\u00adsac\u00adtion volume amounts to appro\u00adxi\u00adm\u00adately EUR 250 million. Derm\u00ada\u00adph\u00adarm is a leading manu\u00adfac\u00adtu\u00adrer of off-patent bran\u00added phar\u00admaceu\u00adti\u00adcals for selec\u00adted markets in [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2020-10-21T09:58:08+00:00","og_image":[{"width":600,"height":600,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/10\/a-weiss_simon.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Themis Beteiligungs AG sells shares in Dermapharm","datePublished":"2020-10-21T09:58:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/"},"wordCount":232,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/10\/a-weiss_simon.jpg","articleSection":["General","Featured","Private equity","News","Lawyers\/Tax-advisors\/Auditors","Lawyers, tax consultants, auditors","Investors"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/","url":"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/","name":"Themis Beteiligungs AG sells shares in Dermapharm - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/10\/a-weiss_simon.jpg","datePublished":"2020-10-21T09:58:08+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/10\/a-weiss_simon.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/10\/a-weiss_simon.jpg","width":600,"height":600,"caption":"Gittings Photography"},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/themis-beteiligungs-ag-sells-shares-in-dermapharm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Themis Beteiligungs AG sells shares in Dermapharm"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/43567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=43567"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/43567\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/35368"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=43567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=43567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=43567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}